文献速递乳腺技术与安全US

临床淋巴结阳性乳腺癌患者新辅助化疗后腋窝病理完全缓解:整合超声再分期影像特征与已知临床病理特征的预测模型

Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
PubMed 文献 · Ultrasound Med Biol · 2018-12-17

本研究纳入227例临床淋巴结阳性乳腺癌患者,在新辅助化疗后、手术前进行腋窝超声再分期,构建仅含临床病理特征的模型及整合超声影像特征的联合模型。106例(46.7%)达到腋窝病理完全缓解;联合模型的c-index为0.783,显著高于仅用临床病理特征模型的0.657(p<0.001)。

要点

  • 腋窝超声再分期中淋巴结脂肪门消失和偏心性皮质增厚缺失与新辅助化疗后腋窝病理完全缓解独立相关。
  • 整合超声再分期影像特征后模型预测能力显著提升,c-index由0.657升至0.783(p<0.001)。
  • 残留肿瘤≤1.5 cm、激素受体阴性、组织学分级较高也与腋窝病理完全缓解独立相关。

核心结论

  • 腋窝超声再分期的影像特征与新辅助化疗后腋窝病理完全缓解独立相关,整合这些特征可显著提高仅用临床病理特征模型的预测能力(c-index 0.783 vs. 0.657,p<0.001)。

研究设计与样本

  • 共227例临床淋巴结阳性乳腺癌患者在新辅助化疗后、手术前接受腋窝超声再分期,构建临床病理模型及整合影像特征的联合模型,用受试者工作特征曲线下面积比较预测价值。

关键影像表现/征象

  • 腋窝淋巴结无脂肪门消失者与新辅助化疗后腋窝病理完全缓解独立相关(OR=14.06)。
  • 腋窝淋巴结无偏心性皮质增厚者与新辅助化疗后腋窝病理完全缓解独立相关(OR=4.42)。

诊断标准与关键数值

  • 多因素分析显示组织学分级中度和高度者腋窝病理完全缓解的OR分别为4.21和10.11。
  • 激素受体阴性者腋窝病理完全缓解的OR=2.88。
  • 残留肿瘤大小≤1.5 cm者腋窝病理完全缓解的OR=2.83。
  • 仅用临床病理特征模型的c-index为0.657,整合超声再分期影像特征后联合模型的c-index为0.783(p<0.001)。

临床应用与阅片要点

  • 在新辅助化疗后腋窝超声再分期中,可关注淋巴结脂肪门是否消失及皮质是否偏心性增厚,并将其纳入腋窝病理完全缓解的预测评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The goal of this study was to evaluate various clinicopathologic and imaging characteristics as independent predictors of axillary pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) and to determine the added value of a model that integrates imaging characteristics of ultrasound (US) restaging with known clinicopathologic characteristics. A total of 227 clinically node-positive breast cancer patients underwent axillary US after NAC (termed US restaging) before surgery. We constructed a clinicopathologic model with independent predictors of clinicopathologic characteristics in multivariate analyses. A combined model was created by integrating imaging characteristics with clinicopathologic characteristics. The predictive values of the models were compared using the area under the receiver operating characteristic curve. Of the 227 patients, 106 (46.7%) achieved axillary pCR. Multivariate analysis revealed that higher histologic grades (odds ratio [OR] = 4.21 and 10.11 for moderate and high grade, respectively), negative hormonal receptor status (OR = 2.88), smaller (≤1.5 cm) residual tumor size (OR = 2.83), absence of fatty hilum loss (OR = 14.06) and absence of eccentric cortical thickening of the axillary lymph node (OR = 4.42) were independently associated with the axillary pCR (all p values < 0.05). Integrating the imaging characteristics of the US restaging significantly increased the predictive capability of the model that applied only the clinicopathologic characteristics (c-index, 0.783 vs. 0.657; p < 0.001). Imaging characteristics of the US restaging were independently associated with axillary pCR after NAC and they significantly improved the predictive capability of the model that used only the clinicopathologic characteristics.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Kim WH, Kim HJ, Park HY, et al. Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics. Ultrasound Med Biol. 2018. PMID: 30567630. doi:10.1016/j.ultrasmedbio.2018.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。